Table 1.
Compd a | R 1 | R 2 | R 3 | R 4 | R 5 | R 6 | MIC b | cLogP c |
---|---|---|---|---|---|---|---|---|
1 |
|
|
|
|
|
> 128 |
−0.77 |
|
2 |
|
|
|
|
|
128 |
−1.08 |
|
3 |
|
|
|
|
|
> 128 |
−0.77 |
|
6a |
PhOCH3-p |
OCH2O |
OCH3 |
OCH3 |
H |
32 |
0.35 |
|
6b |
PhOCH3-m |
OCH2O |
OCH3 |
OCH3 |
H |
16 |
0.35 |
|
6c |
PhCH3-p |
OCH2O |
OCH3 |
OCH3 |
H |
16 |
0.93 |
|
6d |
1-naphthyl |
OCH2O |
OCH3 |
OCH3 |
H |
8 |
1.60 |
|
6e |
n-C10H21 |
OCH2O |
OCH3 |
OCH3 |
H |
2 |
3.29 |
|
7a |
PhOCH3-p |
OCH2O |
H |
OCH3 |
OCH3 |
4 |
0.35 |
|
7b |
PhOCH3-m |
OCH2O |
H |
OCH3 |
OCH3 |
2 |
0.35 |
|
7c |
PhCH3-p |
OCH2O |
H |
OCH3 |
OCH3 |
2 |
0.93 |
|
7d |
PhCl-p |
OCH2O |
H |
OCH3 |
OCH3 |
1 |
1.14 |
|
7e |
PhCl-m |
OCH2O |
H |
OCH3 |
OCH3 |
2 |
1.14 |
|
7f |
1-naphthyl |
OCH2O |
H |
OCH3 |
OCH3 |
2 |
1.60 |
|
7g |
n-C10H21 |
OCH2O |
H |
OCH3 |
OCH3 |
0.5 |
3.29 |
|
7h |
n-C12H25 |
OCH2O |
H |
OCH3 |
OCH3 |
1 |
4.35 |
|
8a |
PhOCH3-p |
OCH3 |
OCH3 |
OCH3 |
OCH3 |
H |
16 |
0.04 |
8b |
PhOCH3-m |
OCH3 |
OCH3 |
OCH3 |
OCH3 |
H |
16 |
0.04 |
8c |
PhCH3-p |
OCH3 |
OCH3 |
OCH3 |
OCH3 |
H |
16 |
0.62 |
8d |
1-naphthyl |
OCH3 |
OCH3 |
OCH3 |
OCH3 |
H |
4 |
1.29 |
8e |
n-C10H21 |
OCH3 |
OCH3 |
OCH3 |
OCH3 |
H |
1 |
2.98 |
RIF |
|
|
|
|
|
0.0625 |
3.90 |
|
INH | 0.0625 | −1.12 |
a: General structural formular is shown in Figure 2.
b: MIC: minimum inhibitory concentration.
c: Chemoffice Ultra 11.0 (Cambridge office).
RIF: rifampin; INH: isoniazid.